Form 4: Charles River Labs Executive Knell Receives Stock Options and Restricted Stock Units
SEC Form 4
Michael Gunnar Knell, CSVP & Chief Accounting Officer of Charles River Laboratories, reports the acquisition of stock options and restricted stock units.
Summary
- Michael Gunnar Knell, a CSVP & Chief Accounting Officer at Charles River Laboratories International, Inc., filed a Form 4 on June 3, 2024, reporting changes in beneficial ownership.
- On May 31, 2024, Knell acquired 648 shares of common stock at $0 and 1,472 stock options with an exercise price of $208.44.
- Following the reported transactions, Knell directly owns 8,326 shares of common stock and 1,472 stock options.
- The stock options vest in four equal installments of 368 shares on May 31st of 2025, 2026, 2027 and 2028, and expire on May 31, 2034.
- The unvested restricted stock units vest in four equal installments of 162 shares on May 31st of 2025, 2026, 2027 and 2028.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock options and restricted stock units is generally a positive sign, but it's not a major event.
Positives
- The acquisition of stock options and restricted stock units suggests confidence in the company's future performance from the executive.
Industry Context
Executive compensation through stock options and restricted stock units is a common practice in publicly traded companies to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotechnology and pharmaceutical services industry.
- Companies like ICON plc and Laboratory Corporation of America Holdings (Labcorp) also utilize stock options and restricted stock units as part of their executive compensation plans.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance.
Stakeholder Impact
- The granting of stock options and restricted stock units can incentivize the executive to improve company performance, which benefits shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 05/31/2025 | First vesting date for stock options (368 shares) and restricted stock units (162 shares). |
| 05/31/2026 | Second vesting date for stock options (368 shares) and restricted stock units (162 shares). |
| 05/31/2027 | Third vesting date for stock options (368 shares) and restricted stock units (162 shares). |
| 05/31/2028 | Fourth vesting date for stock options (368 shares) and restricted stock units (162 shares). |
| 05/31/2034 | Expiration date for stock options. |
| 06/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.